Your browser doesn't support javascript.
loading
Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer Therapies.
Kolberg, Hans-Christian; Hartkopf, Andreas D; Fehm, Tanja N; Welslau, Manfred; Müller, Volkmar; Schütz, Florian; Fasching, Peter A; Janni, Wolfgang; Witzel, Isabell; Thomssen, Christoph; Beierlein, Milena; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P; Aktas, Bahriye; Banys-Paluchowski, Maggie; Kolberg-Liedtke, Cornelia; Wöckel, Achim; Harbeck, Nadia; Stickeler, Elmar; Bartsch, Rupert; Schneeweiss, Andreas; Ettl, Johannes; Krug, David; Taran, Florin-Andrei; Lüftner, Diana; Würstlein, Rachel.
Afiliação
  • Kolberg HC; Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany.
  • Hartkopf AD; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Fehm TN; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Welslau M; Onkologie Aschaffenburg, Aschaffenburg, Germany.
  • Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
  • Schütz F; Gynäkologie und Geburtshilfe, Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Germany.
  • Fasching PA; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Witzel I; Universitätsspital Zürich, Klinik für Gynäkologie, Zürich, Switzerland.
  • Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Beierlein M; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Belleville E; ClinSol GmbH & Co. KG, Würzburg, Germany.
  • Untch M; Clinic for Gynecology and Obstetrics, Breast Cancer Center, Gynecologic Oncology Center, Helios Klinikum Berlin Buch, Berlin, Germany.
  • Thill M; Agaplesion Markus Krankenhaus, Department of Gynecology and Gynecological Oncology, Frankfurt am Main, Germany.
  • Tesch H; Oncology Practice at Bethanien Hospital, Frankfurt am Main, Germany.
  • Ditsch N; Department of Gynecology and Obstetrics, University Hospital Augsburg, Augsburg, Germany.
  • Lux MP; Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderborn, Germany.
  • Aktas B; Department of Gynecology, University of Leipzig Medical Center, Leipzig, Germany.
  • Banys-Paluchowski M; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Kolberg-Liedtke C; Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany.
  • Wöckel A; Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.
  • Harbeck N; Breast Center, Department of Gynecology and Obstetrics and CCC Munich LMU, LMU University Hospital, Munich, Germany.
  • Stickeler E; Department of Obstetrics and Gynecology, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital of RWTH Aachen, Aachen, Germany.
  • Bartsch R; Medical University of Vienna, Department of Medicine I, Division of Oncology, Vienna, Austria.
  • Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Ettl J; Klinikum Kempten, Klinikverbund Allgäu, Klinik für Frauenheilkunde und Gynäkologie, Kempten, Germany.
  • Krug D; Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Strahlentherapie, Kiel, Germany.
  • Taran FA; Department of Gynecology and Obstetrics, University Hospital Freiburg, Freiburg, Germany.
  • Lüftner D; Immanuel Hospital Märkische Schweiz, Buckow, Germany.
  • Würstlein R; Medical University of Brandenburg Theodor-Fontane, Brandenburg, Germany.
Geburtshilfe Frauenheilkd ; 83(9): 1117-1126, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37706055
ABSTRACT
The St. Gallen (SG) International Breast Cancer Conference is held every two years, previously in St. Gallen and now in Vienna. This year (2023) marks the eighteenth edition of this conference, which focuses on the treatment of patients with early-stage breast carcinoma. A panel discussion will be held at the end of this four-day event, during which a panel of experts will give their opinions on current controversial issues relating to the treatment of early-stage breast cancer patients. To this end, questions are generally formulated in such a way that clinically realistic cases are presented - often including poignant hypothetical modifications. This review reports on the outcome of these discussions and summarises the data associated with individual questions raised.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Geburtshilfe Frauenheilkd Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Geburtshilfe Frauenheilkd Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha